Job Listings

Who we are: At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.  

Who we are: At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.  

Who we are: At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.  

Who we are: At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.  

PLEASE NOTE:THE CANDIDATE FOR THIS ROLE MUST RESIDE IN FLORIDA. TERRITORY COVERAGE IS THE SOUTHEAST.   Who we are. Dendreon is making the battle against cancer personal. Our flagship product...

Who we are: At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.  

Who we are: At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.  

Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.   If you are looking to positively impact...